NCT01766167View on ClinicalTrials.gov

Clinical Pharmacology Study of MP-424

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Chronic Hepatitis C
Interventions
DRUG

MP-424

Low

DRUG

MP-424

Middle

DRUG

MP-424

High

DRUG

MP-424

Multiple

Trial Locations (1)

Unknown

Seoul

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY